Ragosa Mark sold KNSA
August 4, 2025 · Form 4 insider transaction
Ragosa Mark sold 18,889 shares of Kiniksa Pharmaceuticals International, plc at $32.89 per share, a transaction worth $621.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
18,889
Price
$32.89
Total value
$621.3K
InsiderRagosa Mark
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateAugust 4, 2025
Filing dateAugust 6, 2025
Shares owned after27,009
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 3, 2024.